ArticleJournal of cancer research and clinical oncology2021

The mechanisms involved in the resistance of estrogen receptor-positive breast cancer cells to palbociclib are multiple and change over time.

Mayu Ono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.